Gadeta is a biotechnology firm at an advanced stage of clinical development, dedicated to creating a revolutionary cellular immunotherapy for combating cancer. Employing a range of exclusive T-cell engineering and production methods, Gadeta is at the forefront of crafting ?? T-cells designed to express specific ?? T-cell receptors capable of targeting cancer cells. Gadeta harnesses the distinctive attributes of ?? T cell receptors (TCRs) to effectively identify both blood-related and solid tumor cells, with potential applications in treating complex malignancies.